CMS has issued its scheduled quarterly update for ASC rates of certain drugs and biologics, according to an ASCA report.
CMS has added two drugs/biologics (HCPCS C9292 Injection perttzumab, 10 mg and HCPCS C9293 Injection, glucarpidase, 10 units) to the ASC list of payable drugs/biologics effective Oct. 1, 2012.
The list of covered ancillary services for 2012 has been updated on ASCA's website here.
Related Articles on Coding, Billing and Collections:
How to Successfully Handle Out-of-Network Contracts in ASCs
Maine Physician Pays $321K to Settle False Billing Claims
5 Tactics to Negotiate Bundled Payments for Surgery Centers
CMS has added two drugs/biologics (HCPCS C9292 Injection perttzumab, 10 mg and HCPCS C9293 Injection, glucarpidase, 10 units) to the ASC list of payable drugs/biologics effective Oct. 1, 2012.
The list of covered ancillary services for 2012 has been updated on ASCA's website here.
Related Articles on Coding, Billing and Collections:
How to Successfully Handle Out-of-Network Contracts in ASCs
Maine Physician Pays $321K to Settle False Billing Claims
5 Tactics to Negotiate Bundled Payments for Surgery Centers